Methylation of tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression

被引:159
作者
Boulanger, MC
Liang, C
Russell, RS
Lin, RT
Bedford, MT
Wainberg, MA
Richard, S
机构
[1] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada
[2] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada
[4] McGill Univ, Dept Microbiol, Montreal, PQ H3A 2T5, Canada
[5] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada
[6] McGill Univ, Dept Oncol, Montreal, PQ H3A 2T5, Canada
[7] Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA
关键词
D O I
10.1128/JVI.79.1.124-131.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus (HIV) transactivator protein, Tat, stimulates transcription from the viral long terminal repeats via an arginine-rich transactivating domain. Since arginines are often known to be methylated, we investigated whether HIV type 1 (HIV-1) Tat was a substrate for known protein arginine methyltransferases (PRMTs). Here we identify Tat as a substrate for the arginine methyltransferase, PRMT6. Tat is specifically associated with and methylated by PRMT6 within cells. Overexpression of wild-type PRMT6, but not a methylase-inactive PRMT6 mutant, decreased Tat transactivation of an HIV-1 long terminal repeat luciferase reporter plasmid in a dose-dependent manner. Knocking down PRMT6 consistently increased HIV-1 production in HEK293T cells and also led to increased viral infectiousness as shown in multinuclear activation of a galactosidase indicator assays. Our study demonstrates that arginine methylation of Tat negatively regulates its transactivation activity and that PRMT6 acts as a restriction factor for HIV replication.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 43 条
[1]   Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53 [J].
An, W ;
Kim, J ;
Roeder, RG .
CELL, 2004, 117 (06) :735-748
[2]   Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains [J].
Bedford, MT ;
Frankel, A ;
Yaffe, MB ;
Clarke, S ;
Leder, P ;
Richard, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :16030-16036
[3]   Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing [J].
Boisvert, FM ;
Côté, J ;
Boulanger, MC ;
Cléroux, P ;
Bachand, F ;
Autexier, C ;
Richard, S .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :957-969
[4]   A proteomic analysis of arginine-methylated protein complexes [J].
Boisvert, FM ;
Côté, J ;
Boulanger, MC ;
Richard, S .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (12) :1319-1330
[5]   Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences [J].
Bourgeois, CF ;
Kim, YK ;
Churcher, MJ ;
West, MJ ;
Karn, J .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (04) :1079-1093
[6]   PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins [J].
Branscombe, TL ;
Frankel, A ;
Lee, JH ;
Cook, JR ;
Yang, ZH ;
Pestka, S ;
Clarke, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :32971-32976
[7]   Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF [J].
Brès, V ;
Tagami, H ;
Péloponèse, JM ;
Loret, E ;
Jeang, KT ;
Nakatani, Y ;
Emiliani, S ;
Benkirane, M ;
Kiernan, RE .
EMBO JOURNAL, 2002, 21 (24) :6811-6819
[8]   Regulation of transcription by a protein methyltransferase [J].
Chen, DG ;
Ma, H ;
Hong, H ;
Koh, SS ;
Huang, SM ;
Schurter, BT ;
Aswad, DW ;
Stallcup, MR .
SCIENCE, 1999, 284 (5423) :2174-2177
[9]   Small molecule regulators of protein arginine methyltransferases [J].
Cheng, DH ;
Yadav, N ;
King, RW ;
Swanson, MS ;
Weinstein, EJ ;
Bedford, MT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :23892-23899
[10]   Control of CBP co-activating activity by arginine methylation [J].
Chevillard-Briet, M ;
Trouche, D ;
Vandel, L .
EMBO JOURNAL, 2002, 21 (20) :5457-5466